Bayer made to tone down aspirin advertisementsBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7229.208/c (Published 22 January 2000) Cite this as: BMJ 2000;320:208
- Deborah Josefson
- San Francisco
The pharmaceutical giant, Bayer, has agreed to mute its advertisements, which propagate the idea that daily use of aspirin is beneficial for all adults.
The agreement comes after the US Federal Trade Commission and the US Department of Justice charged that Bayer's aggressive aspirin marketing campaigns are misleading and may lead to medical complications in uneducated consumers.
In particular, officials were concerned that Bayer made unsubstantiated claims that regular intake of aspirin could prevent myocardial infarcts and ischaemic stroke in healthy adults.
While there is substantial and incontrovertible evidence …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.